Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Intimation of Board ....
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics has informed the stock exchanges that its Board of Directors will meet on Thursday, November 13, 2025, at its registered office in Mumbai. The main agenda is to consider and approve the unaudited financial results, both standalone and consolidated, for the second quarter ending September 30, 2025 (Q2 FY26). The company is listed on both BSE (Scrip Code: 532637) and NSE (Symbol: MANGALAM). This is a routine advance intimation filed under SEBI's Listing Obligations and Disclosure Requirements rules. Additionally, the trading window for directors, officers, and designated employees has been closed since October 1, 2025 and will stay closed until 48 hours after the Q2 results are publicly announced.
This is a standard pre-results announcement with no business decision being made yet. Investors should mark November 13 for the Q2 FY26 earnings release, which could influence short-term stock movement depending on the numbers and how they compare with market expectations.